Cargando…

Pharmacology, selection and complications associated with neuromuscular blocking drugs in ICU patients.

Detalles Bibliográficos
Autor principal:	Prielipp, R. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Yale Journal of Biology and Medicine 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2578942/ https://www.ncbi.nlm.nih.gov/pubmed/10604780

Ejemplares similares

Neuromuscular blockade management in the critically Ill patient
por: Renew, J. Ross, et al.
Publicado: (2020)

Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review
por: Hafeez, Khawaja Rashid, et al.
Publicado: (2018)

Sugammadex: A revolutionary drug in neuromuscular pharmacology
por: Nag, Kusha, et al.
Publicado: (2013)

Prolonged neuromuscular block associated with cholinesterase deficiency
por: Zhang, Chao, et al.
Publicado: (2018)

Reversal of neuromuscular block
por: Bhalotra, Anju Romina
Publicado: (2018)

Prolonged use of neuromuscular blocking agents is associated with increased long-term mortality in mechanically ventilated medical ICU patients: a retrospective cohort study
por: Lin, Chun, et al.
Publicado: (2023)

Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications
por: Cho, Sung-Ae, et al.
Publicado: (2022)

NEUROMUSCULAR BLOCKING AGENT BUNDLES IN THE MEDICAL ICU TO PREVENT PROLONGED USE OF PARALYTICS IN PATIENTS WITH COVID-19-RELATED ARDS
por: PINCHOVER, ZACHARY S, et al.
Publicado: (2022)

On the relationship between inhibition and receptor occupancy by nondepolarizing neuromuscular blocking drugs
por: Hoshino, Hikaru, et al.
Publicado: (2021)

The Clinical Pharmacology of Beta Adrenergic Blocking Drugs
por: McDevitt, D. G., et al.
Publicado: (1976)

EXPERIMENTS ON THE ROLE OF POTASSIUM IN THE BLOCKING OF NEUROMUSCULAR TRANSMISSION BY CURARE AND OTHER DRUGS
por: Fenn, Wallace O., et al.
Publicado: (1951)

THE ELECTROPHYSIOLOGY AND PHARMACOLOGY OF LOBSTER NEUROMUSCULAR SYNAPSES
por: Grundfest, H., et al.
Publicado: (1959)

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
por: Higashi, Michiko, et al.
Publicado: (2019)

Flexible organic frameworks sequester neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo
por: Wu, Yan, et al.
Publicado: (2022)

Iatrogenic complications in ICU patients
por: Laskou, M, et al.
Publicado: (2006)

A survey of the current use of neuromuscular blocking drugs among the Middle Eastern anesthesiologists
por: Eldawlatly, Abdelazeem, et al.
Publicado: (2013)

Volume of the effect compartment in simulations of neuromuscular block
por: Nigrovic, Vladimir, et al.
Publicado: (2005)

Considerations in Neuromuscular Blockade in the ICU: A Case Report and Review of the Literature
por: Workum, Jessica D., et al.
Publicado: (2020)

Reversal of neuromuscular block: what are the costs?
por: Bartels, Karsten, et al.
Publicado: (2023)

Effects of neuromuscular blocking drugs on viability of human umbilical vein endothelial cells (HUVECs)
por: Doğan, Sevil Ceyhan, et al.
Publicado: (2020)

Neuromuscular Scoliosis: Comorbidities and Complications
por: Weissmann, Karen Andrea, et al.
Publicado: (2021)

Carboxymethyl-γ-cyclodextrin, a novel selective relaxant binding agent for the reversal of neuromuscular block induced by aminosteroid neuromuscular blockers: an ex vivo laboratory study
por: Fábián, Ákos I., et al.
Publicado: (2021)

Fatigue and activity-dependent conduction block in neuromuscular disorders
por: Tsuneyama, Atsuko, et al.
Publicado: (2022)

A Novel Striated Muscle-Specific Myosin-Blocking Drug for the Study of Neuromuscular Physiology
por: Heredia, Dante J., et al.
Publicado: (2016)

Update on the management of neuromuscular block: focus on sugammadex
por: de Boer, Hans D, et al.
Publicado: (2007)

Tracheal intubation without neuromuscular block in children
por: Shaikh, Safiya I, et al.
Publicado: (2010)

Recent advances in neuromuscular block during anesthesia
por: Boon, Martijn, et al.
Publicado: (2018)

Neuromuscular blocking agents in the intensive care unit
por: Rodríguez-Blanco, Jonathan, et al.
Publicado: (2022)

Titration of Pharmacological Responses in ICU Patients by Quantified EEG
por: Pastor, Jesús, et al.
Publicado: (2023)

Residual neuromuscular block in the postanesthesia care unit: incidence, risk factors, and effect of neuromuscular monitoring and reversal agents
por: ÖZBEY, Nazlı Bahar, et al.
Publicado: (2022)

Predictive study of pharmacological reversal for residual neuromuscular blockade and postoperative pulmonary complications: a prospective, observational, cohort study
por: Aragón-Benedí, Cristian, et al.
Publicado: (2022)

Neuromuscular block in patients 80 years and older: a prospective, controlled study
por: Schmartz, Denis, et al.
Publicado: (2021)

Transesophageal echocardiographic imaging workshop: a basic transverse plane examination sequence.
por: Griffin, M., et al.
Publicado: (1998)

A retrospective study of sugammadex for reversal of neuromuscular blockade induced by rocuronium in critically ill patients in the ICU
por: Bologheanu, Răzvan, et al.
Publicado: (2022)

Neuromuscular sonography detects changes in muscle echotexture and nerve diameter in ICU patients within 24 h
por: Bulinski, Catherine, et al.
Publicado: (2021)

Application of Neuromuscular Blockers in Patients with ARDS in ICU: A Retrospective Study Based on the MIMIC-III Database
por: Pan, Xiaojun, et al.
Publicado: (2023)

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
por: Honore, Patrick M., et al.
Publicado: (2020)

Management of Patients with the Intravascular Ventricular Assist System (iVAS) for Non-Cardiac Surgery
por: Karuppiah, Sathappan, et al.
Publicado: (2022)

Deep neuromuscular block reduces the incidence of intra-operative complications during laparoscopic donor nephrectomy: a pooled analysis of randomized controlled trials
por: Reijnders-Boerboom, Gabby T. J. A., et al.
Publicado: (2021)

Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
por: Wefki Abdelgawwad Shousha, Ahmed Abdelgawwad, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4bv6q135kr8lsgq450l1rlsdvn